Anti-MGMT monoclonal antibody

Pre-made anti-MGMT monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MGMT/MGMT products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T24587-Ab-1/ GM-Tg-hg-T24587-Ab-2Anti-Human MGMT monoclonal antibodyHuman
GM-Tg-rg-T24587-Ab-1/ GM-Tg-rg-T24587-Ab-2Anti-Rat MGMT monoclonal antibodyRat
GM-Tg-mg-T24587-Ab-1/ GM-Tg-mg-T24587-Ab-2Anti-Mouse MGMT monoclonal antibodyMouse
GM-Tg-cynog-T24587-Ab-1/ GM-Tg-cynog-T24587-Ab-2Anti-Cynomolgus/ Rhesus macaque MGMT monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T24587-Ab-1/ GM-Tg-felg-T24587-Ab-2Anti-Feline MGMT monoclonal antibodyFeline
GM-Tg-cang-T24587-Ab-1/ GM-Tg-cang-T24587-Ab-2Anti-Canine MGMT monoclonal antibodyCanine
GM-Tg-bovg-T24587-Ab-1/ GM-Tg-bovg-T24587-Ab-2Anti-Bovine MGMT monoclonal antibodyBovine
GM-Tg-equg-T24587-Ab-1/ GM-Tg-equg-T24587-Ab-2Anti-Equine MGMT monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T24587-Ab-1/ GM-Tg-hg-T24587-Ab-2; GM-Tg-rg-T24587-Ab-1/ GM-Tg-rg-T24587-Ab-2;
GM-Tg-mg-T24587-Ab-1/ GM-Tg-mg-T24587-Ab-2; GM-Tg-cynog-T24587-Ab-1/ GM-Tg-cynog-T24587-Ab-2;
GM-Tg-felg-T24587-Ab-1/ GM-Tg-felg-T24587-Ab-2; GM-Tg-cang-T24587-Ab-1/ GM-Tg-cang-T24587-Ab-2;
GM-Tg-bovg-T24587-Ab-1/ GM-Tg-bovg-T24587-Ab-2; GM-Tg-equg-T24587-Ab-1/ GM-Tg-equg-T24587-Ab-2
Products NameAnti-MGMT monoclonal antibody
Formatmab
Target NameMGMT
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MGMT monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T24587-Ag-1Recombinant multi-species MGMT protein
    ORF Viral VectorpGMLP004946human Mgmt Lentivirus plasmid
    ORF Viral VectorvGMLV000629human MGMT Lentivirus particle
    ORF Viral VectorvGMLP004946human Mgmt Lentivirus particle
    ORF Viral VectorpGMLV000629human MGMT Lentivirus plasmid
    ORF Viral VectorpGMLPm000491mouse Mgmt Lentivirus plasmid
    ORF Viral VectorvGMLPm000491mouse Mgmt Lentivirus particle


    Target information

    Target IDGM-T24587
    Target NameMGMT
    Gene ID4255,17314,25332,698134,442978,101085076,616091,100049801
    Gene Symbol and SynonymsAgat,AGT,MGMT
    Uniprot AccessionP16455,P24528,Q6TDU1,P29177
    Uniprot Entry NameMGMT_HUMAN,MGMT_RAT,MGMT_CANLF,MGMT_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseLung Cancer
    Gene EnsemblENSG00000170430
    Target ClassificationN/A

    The target: MGMT, gene name: MGMT, also named as . Alkylating agents are potent carcinogens that can result in cell death, mutation and cancer. The protein encoded by this gene is a DNA repair protein that is involved in cellular defense against mutagenesis and toxicity from alkylating agents. The protein catalyzes transfer of methyl groups from O(6)-alkylguanine and other methylated moieties of the DNA to its own molecule, which repairs the toxic lesions. Methylation of the genes promoter has been associated with several cancer types, including colorectal cancer, lung cancer, lymphoma and glioblastoma. [provided by RefSeq, Sep 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.